| Donor-specific antibodies and primary graft failure in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis Y Xie, J Parekh, Z Tang, D Wu, X Wu Transplantation and Cellular Therapy 27 (8), 687. e1-687. e7, 2021 | 22 | 2021 |
| Monitoring tyrosine kinase inhibitor therapeutic responses with a panel of metabolic biomarkers in chronic myeloid leukemia patients B Yang, C Wang, Y Xie, L Xu, X Wu, D Wu Cancer Science 109 (3), 777-784, 2018 | 18 | 2018 |
| Long term adherence to continuous positive Airway pressure in mild obstructive sleep apnea M Qiao, Y Xie, A Wolff, J Kwon BMC Pulmonary Medicine 23 (1), 320, 2023 | 17 | 2023 |
| Prediction of acute GVHD and relapse by metabolic biomarkers after allogeneic hematopoietic stem cell transplantation X Wu, Y Xie, C Wang, Y Han, X Bao, S Ma, A Yilmaz, B Yang, Y Ji, J Xu, ... JCI insight 3 (9), 2018 | 17 | 2018 |
| Case report: a case with Philadelphia chromosome positive T-cell lymphoblastic lymphoma and a review of literature X Li, N Ping, Y Wang, X Xu, L Gao, Z Zeng, L Zhang, Z Zhang, Y Xie, ... Frontiers in Oncology 10, 584149, 2021 | 13 | 2021 |
| The impact of Rituximab administered before transplantation in patients undergoing allogeneic hematopoietic stem cell transplantation: a real-world study X Wei, Y Xie, R Jiang, H Li, H Wu, Y Zhang, L Li, S Zhou, X Ma, Z Tang, ... Frontiers in Immunology 13, 967026, 2022 | 7 | 2022 |
| The clinical and molecular characteristics of FLT3 mutations in Chinese de novo adolescent and adult acute lymphoblastic leukemia patients Z Shen, XL Chu, RX Wang, JL Li, MY Liu, YY Xie, C Wang, R Han, JQ Yu, ... Clinical Lymphoma Myeloma and Leukemia 20 (6), e259-e269, 2020 | 6 | 2020 |
| Identification of metabolic biomarkers to predict treatment outcome and disease progression in multiple myeloma R Zhao, Y Xie, B Yang, C Wang, Q Huang, Y Han, L Yang, S Yan, X Wang, ... American journal of cancer research 10 (11), 3935, 2020 | 6 | 2020 |
| Relationship of oropharyngeal colonization microorganisms to clinical outcomes within 100 days after allogeneic hematopoietic stem cell transplantation J Ge, X Wei, Y Gu, Y Xie, H Li, S Zhou, C Liu, S Li, W Wu, J Xu, X Ma, ... Transplantation and Cellular Therapy 28 (8), 496. e1-496. e7, 2022 | 5 | 2022 |
| Lenalidomide, bortezomib and dexamethasone followed by tandem-autologous stem cell transplantation is an effective treatment modality for multi-hit multiple myeloma S Tang, Y Lu, P Zhang, D Chen, X Liu, X Du, J Cao, P Ye, L Chen, S Li, ... Leukemia Research 110, 106710, 2021 | 4 | 2021 |
| Effects of donor-engrafted clonal hematopoiesis in allogeneic and autologous stem cell transplantation: a systematic review and meta-analysis Y Xie, V Kazakova, LD Weeks, JM Gerber, J Tai, TY Zhang, R Lowsky, ... Bone Marrow Transplantation 59 (11), 1585-1593, 2024 | 2 | 2024 |
| Application of multiplex PCR assay to study early multiple herpesviruses infection during HSCT YH Ji, ZL Zhu, LL Yang, YY Xie, J Chen, H Liu, X Ma, YJ Liu, J He, Y Han, ... Zhonghua xue ye xue za zhi= Zhonghua Xueyexue Zazhi 40 (2), 125-131, 2019 | 2 | 2019 |
| Neoadjuvant immunotherapy in hepatocellular carcinoma: A systematic review and meta-analysis. J Parekh, S Abraham, H Andanamala, A Rehman, Y Xie, Y Adjepong, ... Journal of Clinical Oncology 41 (16_suppl), e16232-e16232, 2023 | | 2023 |
| Laterality and survival in mesothelioma: A SEER database analysis. J Parekh, A Yerlikaya, Y Xie, Y Eralp, Y Adjepong Journal of Clinical Oncology 40 (16_suppl), e20594-e20594, 2022 | | 2022 |
